Company / Cash per Share
Phio Pharmaceuticals Corp. Cash per Share History
FY2012-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.75
FY2017
5-year range
$1.97 / $2.75
FY2013-FY2017
Trend
+39.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has increased for 3 consecutive years, from $0.01 in FY2012 to $2.75 in FY2017.
Based on SEC 10-K filings.
2.75 in FY2017 with a 5-year CAGR of +253.2%.
Improved from $0.97 to $2.75 over the past 4 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +253.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Phio Pharmaceuticals Corp.'s cash per share has grown for 3 consecutive years.
- In FY2017, cash per share increased 39.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $2.75 | +39.4% |
| FY2016 | $1.97 | +103.7% |
| FY2013 | $0.97 | +19256.5% |
| FY2012 | $0.01 | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026